Physician profile
John Pool
NPI 1134338114
$42,246.58
in general payments reported to CMS, 2019-2025
13 companies · $86.24 in 2025
The $86.24 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26K · 2020: $1,281 · 2021: $6,787 · 2022: $1,501 · 2023: $5,956 · 2024: $740 · 2025: $86.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $5,500 · Food and Beverage: $1,282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $5,500.00 |
| Food and Beverage | $1,282.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $25,153.12 | 2019-2024 | |
| Medtronic, INC. | $13,026.93 | 2021-2024 | Corevalve Evolut R |
| Medtronic Vascular, INC. | $1,652.10 | 2019-2020 | |
| Abiomed | $1,165.74 | 2022-2024 | Impella |
| Edwards Lifesciences Corporation | $546.74 | 2019-2024 | Konect Resilia |
| Abbott Laboratories | $264.19 | 2020-2023 | Portico |
| Intact Vascular, INC. | $175.00 | 2019 | |
| Atricure, INC. | $116.18 | 2024-2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $75.80 | 2024 | |
| Siemens Medical Solutions USA, INC. | $20.41 | 2019 | |
| Ethicon US, LLC | $19.52 | 2021 | |
| Bard Access Systems, INC. | $19.05 | 2021 | |
| Kls-Martin L.P. | $11.80 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Pool listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.